Evidence Based Clinical Chinese Medicine Volume 17 Colorectal Cancer

This seventeenth volume of the Evidence-based Clinical Chinese Medicine series aims to provide a multi-faceted 'whole evidence' analysis of the management of Colorectal Cancer in integrative Chinese medicine.Beginning with overviews of how colorectal cancer is conceptualised and managed in both conventional medicine and contemporary Chinese medicine, the authors then provide detailed analyses of how colorectal cancer and related disorders were treated with herbal medicine and acupuncture in past eras.In the subsequent chapters, the authors comprehensively review the current state of the clinical trial evidence for Chinese herbal medicines (Chapter 5), acupuncture (Chapter 7), other Chinese medicine therapies (Chapter 8) and combination Chinese medicine therapies (Chapter 9) in the management of colorectal cancer, as well as analyse and evaluate the results of these studies from an evidence-based medicine perspective. Chapter 6 provides a review and a summary of the experimental evidence for the bioactivity of commonly used Chinese herbs. The outcomes of these analyses are summarised and discussed in Chapter 10 which identifies implications for the clinical practice of Chinese medicine and for future research.This book can inform clinicians and students in the fields of integrative medicine and Chinese medicine regarding contemporary practice and the current evidence-base for a range of Chinese medicine therapies used in the management of colorectal cancer, including herbal formulas and acupuncture treatments, in order to assist clinicians in making evidence-based decisions in patient care.The following features mark the importance of this book in the field:

This eighteenth volume of the Evidence-based Clinical Chinese Medicine series aims to provide a multi-faceted "whole evidence" analysis of the management of pain due to a range of cancers (cancer pain) using integrative Chinese medicine. Beginning with an overview of how cancer pain is conceptualised and managed in conventional medicine, the authors then summarise the differential diagnosis and managment of cancer pain in contemporary Chinese medicine based on clinical guidelines and contemporary books. The third chapter provides detailed analyses of how cancer pain and related disorders were treated with herbal medicine and acupuncture in past eras based on the classical Chinese medical literature. The subsequent chapters comprehensively review the current state of the clinical trial evidence for the integrative application of Chinese herbal medicines (Chapter 5), acupuncture (Chapter 7), other Chinese medicine therapies (Chapter 8) and combination Chinese medicine therapies (Chapter 9) in the management of cancer pain, as well as analyse and evaluate the results of these studies from an evidence-based medicine perspective. Chapter 6 reviews and summarises experimental evidence for the bioactivity of commonly used Chinese herbs and their constituent compounds. The outcomes of these analyses are summarised and discussed in Chapter 10 which alsoidentifies implications for the clinical practice of Chinese medicine and for future research. This book can inform clinicians and students in the fields of integrative medicine and Chinese medicine regarding contemporary practice and the current evidence base for a range of Chinese medicine therapies used in the management of cancer pain, including herbal formulas and acupuncture treatments, in order to assist clinicians in making evidence-based decisions in patient care. It also provides researchers with a comprehensive summary of the state of the field than can inform future. The following features mark the importance of this book in the field: An innovative "whole evidence" approach - This book combines multiple types of evidence from multiple sources to provide a unique and comprehensive assessment of the available evidence for Chinese medicine in cancer pain. Clinically informative and relevant - This book integrates the results of meta-analyses of clinical trial data with evidence from the classical Chinese medicine literature, and the recommendations in contemporary textbooks and clinical guidelines for the application of Chinese medicine in cancer pain using syndrome differentiation. Developed by a skilled team - The authors are internationally recognize, well-respected leaders in the field of Chinese medicine and evidence-based medicine with strong track records in research with multiple publications in the field of cancer.

Irritable bowel syndrome is a type of functional bowel disorder causing symptoms of abdominal pain and altered bowel habits such as diarrhoea (IBS-D) and constipation (IBS-C). This book uses the 'whole evidence' approach to give an overview of the available evidence for Chinese medicine treatment for irritable bowel syndrome, particularly subtypes IBS-D and IBS-C.The book starts by summarising the conventional understanding of irritable bowel syndrome, including its subtypes, aetiology, diagnosis and current available treatments. Data from Chinese medicine classical literature and clinical studies are then discussed. Evidence from clinical studies are evaluated using high-quality and rigorous scientific methodology. For IBS-D and IBS-C, evidence from treatment modalities including Chinese herbal medicine, acupuncture and combination Chinese medicine therapies are presented. The findings are analysed and potential implications for clinical practice and research are explored. Experimental studies that describe the potential mechanisms of action of key herbs are summarised. In the final chapter, current evidence of Chinese medicine for IBS-D and IBS-C are synthesised, recommendations for contemporary clinical practice and future research are also offered.The book is a helpful guide for clinicians and students of Chinese and integrative medicine, offering a comprehensive synthesis of both classical and contemporary knowledge that can integrated into their clinical practice for people with irritable bowel syndrome.

This eighteenth volume of the Evidence-based Clinical Chinese Medicine series aims to provide a multi-faceted 'whole evidence' analysis of the management of pain due to a range of cancers (cancer pain) using integrative Chinese medicine.Beginning with an overview of how cancer pain is conceptualised and managed in conventional medicine, the authors then summarise the differential diagnosis and managment of cancer pain in contemporary Chinese medicine based on clinical guidelines and contemporary books. The third chapter provides detailed analyses of how cancer pain and related disorders were treated with herbal medicine and acupuncture in past eras based on the classical Chinese medical literature.The subsequent chapters comprehensively review the current state of the clinical trial evidence for the integrative application of Chinese herbal medicines (Chapter 5), acupuncture (Chapter 7), other Chinese medicine therapies (Chapter 8) and combination Chinese medicine therapies (Chapter 9) in the management of cancer pain, as well as analyse and evaluate the results of these studies from an evidence-based medicine perspective. Chapter 6 reviews and summarises experimental evidence for the bioactivity of commonly used Chinese herbs and their constituent compounds. The outcomes of these analyses are summarised and discussed in Chapter 10 which alsoidentifies implications for the clinical practice of Chinese medicine and for future research.This book can inform clinicians and students in the fields of integrative medicine and Chinese medicine regarding contemporary practice and the current evidence base for a range of Chinese medicine therapies used in the management of cancer pain, including herbal formulas and acupuncture treatments, in order to assist clinicians in making evidence-based decisions in patient care. It also provides researchers with a comprehensive summary of the state of the field than can inform future.The following features mark the importance of this book in the field:

The 27th volume of the Evidence-based Clinical Chinese Medicine series examines the management of people who are overweight and obese with Chinese medicine using a 'whole evidence' approach. Overweight and obesity are recognised as leading health concerns worldwide. They have significant impacts on quality of life and mortality and are associated with many complications and chronic illnesses, including diabetes mellitus, cardiovascular disease, hypertension, stroke and some cancers. Conventional medicine understanding of weight gain, including common causes, diagnosis and treatment are included, along with the Chinese medicine conceptualisation of overweight and obesity.Evidence from clinical studies is reviewed using internationally accepted scientific methods. Systematic reviews describe the treatments used in clinical studies, and analyse the effectiveness of Chinese herbal medicines, acupuncture and related therapies, other Chinese medicine therapies, and combinations of Chinese medicine therapies. Experimental studies that describe the potential mechanisms of action of key herbs are summarised. The final chapter synthesises the current evidence and offers suggestions for contemporary clinical practice and future research.This book is a handy desktop reference for both clinicians and students of Chinese and integrative medicine. It provides a comprehensive synthesis of both traditional and contemporary knowledge that can inform clinical decision-making.

This 26th volume of the Evidence-based Clinical Chinese Medicine series provides a multi-faceted 'whole evidence' analysis of the management of rheumatoid arthritis (RA) using integrative Chinese medicine. Beginning with an overview of how RA is conceptualised and managed in conventional medicine (Chapter 1), the authors summarise the syndrome differentiation and management of RA in contemporary Chinese medicine (Chapter 2), based on clinical guidelines and contemporary books. Chapter 3 provides detailed analyses of how RA and related conditions were treated with herbal medicine and acupuncture in past eras based on the classical Chinese medical literature. The subsequent chapters comprehensively review the current state of the clinical evidence for the integrative application of Chinese herbal medicines (Chapter 5), acupuncture therapies (Chapter 7), other Chinese medicine therapies (Chapter 8) and combination Chinese medicine therapies (Chapter 9), as well as analyse and evaluate the results of these clinical studies from an evidence-based medicine perspective. Chapter 6 reviews and summarises experimental evidence for the bioactivity of commonly used Chinese herbs and their constituent compounds. The outcomes of these analyses are summarised and discussed in Chapter 10. Implications for clinical practice and future research are identified. This book informs clinicians and students in the fields of integrative medicine and Chinese medicine regarding contemporary practice and the current evidence base for Chinese medicine therapies for managing RA. It enables clinicians in making evidence-based decisions in patient care. It also provides researchers with a comprehensive survey of the state of the field that can inform future directions for clinical and experimental studies.